TP53 and prostate cancer: Moreover, the KEGG pathway enrichment analysis of these down-regulated DEGs shows that they are involved in the main event of cancers, and prostate carcinoma including pathways in cancer, p53 signaling pathway, prostate cancer, apoptosis, and MicroRNAs in cancer.